Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$6.64 USD
+0.08 (1.22%)
Updated May 16, 2024 04:00 PM ET
After-Market: $6.63 -0.01 (-0.15%) 5:40 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 801 - 820 ( 1015 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 28
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Begins a Phase IIa Study of IW- 3718 in the Refractory Gastroesophageal Reflux Setting
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Begins a Phase IIa Study of IW- 3718 in the Refractory Gastroesophageal Reflux Setting
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 7
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C